Presentation ESC 2025 DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation Presenter: Mohamed Abdel-Wahab August 29, 2025
Presentation TCT 2024 TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques Presenter: Sukhdeep Basra October 30, 2024
Presentation TCT 2024 Pulmonary Intervention for Structural Interventionalist: My Best Tips and Tricks for Avoiding Pitfalls and Tackling Challenges Presenter: Barry Love October 29, 2024
Presentation TCT 2024 The Landscape of Current TAVR Technologies for AR Treatment: Are Anatomical Needs Being Addressed? Presenter: Vinod Thourani October 29, 2024
Presentation TCT 2024 TAVR (VitaFlow) in Patients with Severe Aortic Regurgitation Using a Novel Anatomical Classification and Dual Anchoring Theory: 30-Day Results from the AURORA Trial Presenter: Nicolo Piazza October 29, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Repair for Aortic Insufficiency Using the Cusper Device Presenter: Yair Feld October 29, 2024
Presentation TCT 2024 Early Results of Multi-Center Trial of a Novel Balloon-Expandable Valve with Anchor (Hanchor) for Aortic Regurgitation Presenter: Wenzhi Pan October 29, 2024
Presentation TCT 2024 Early Experience with the LagunaTech Balloon-Expandable TAVR for Non-Calcific Regurgitation and Calcific Stenosis – Consistent Landing Height with a Short-Framed Valve Presenter: D. Scott Lim October 29, 2024
Presentation TCT 2024 The Interventional Cardiologist’s Perspective: Which Primary MR Patients Should Be Referred For Surgery? Presenter: Paul Sorajja October 29, 2024
Presentation TCT 2024 The Interventionalist’s Perspective: Therapeutic Options and Outcomes Presenter: Jason Rogers October 29, 2024
Presentation TCT 2024 Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment? Presenter: Laura Davidson October 29, 2024
Presentation NY Valves 2024 When to Consider TAVR Explant Or Redo ADR Surgery Presenter: Michael A. Borger June 07, 2024
Presentation NY Valves 2024 CT Interrogation & Procedure Simulations of Failing Surgical Valves Presenter: Vinod H. Thourani June 07, 2024
Presentation NY Valves 2024 Valve Fracturing During Surgical Valve-in-Valve Procedures Presenter: Keith B. Allen June 07, 2024
Presentation NY Valves 2024 Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients Presenter: Nino Mihatov June 07, 2024
Presentation NY Valves 2024 How to Define and Manage Subclinical Leaflet Thrombosis Presenter: Hasan Jilaihawi June 07, 2024
Presentation NY Valves 2024 Histopathology From Explanted Valves in Patients With HALT and RLM Presenter: Stephanie Sellers June 07, 2024
Presentation NY Valves 2024 Arial View of Antithrombotic Therapy Post TAVR Presenter: Thomas Pilgrim June 07, 2024
Presentation NY Valves 2024 Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort! Presenter: Azeem Latib June 07, 2024
Presentation NY Valves 2024 Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand! Presenter: Rishi Puri June 07, 2024